Ph.D., Co-founder and Program Director, Life Science Technologies, imec
Liesbet Lagae oversees the emerging R&D, the public funded activities and early business creation. She holds a PhD degree from the KU Leuven, Belgium for her work on Magnetic Random Access Memories obtained under an IWT grant. As a young group leader, she has initiated the field of molecular and cellular biochips leveraging silicon technologies at IMEC, Belgium. The life science program has grown from emerging activities to a mature business line that provides smart silicon chip solutions to the life science industry. Applications include medical diagnostics, point-of-care solutions, DNA sequencing, cytometry, bioreactors, neuroprobes, implants. She holds a prestigious ERC consolidator grant for developing a platform on single cell analysis and sorting. She has (co-) authored 150 peer-reviewed papers in international journals and holds 15 patents in the field.
Liquid Biopsy Showcase: imec
Imec is the world-leading R&D and innovation hub in nanoelectronics and digital technologies. As a trusted partner for companies, startups and academia we bring together brilliant minds from all over the world in a creative and stimulating environment.
Liquid Biopsies Go Digital
Making liquid biopsies part of standard personalized medicine requires development of next-generation point-of-care devices able to reach clinically meaningful sensitivities, simplify sample preparation, as well as reduce costs and footprint of the instruments. An integrated end-to-end approach, from microfluidic cell capture and sorting of relevant cell populations, to rapid on-chip sample preparation, PCR and data analysis, will enable full exploitation of the potential utility of liquid biopsies in aiding clinical decision and improving patient outcomes.